Cardiol Therapeutics Inc. (CRDL)
USD 1.08
(8.64%)
USD 1.08
(8.64%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -279.87 Thousand CAD | 0.0% |
| 2022 | - CAD | 0.0% |
| 2021 | - CAD | -100.0% |
| 2020 | 17.96 Thousand CAD | -98.39% |
| 2019 | 1.11 Million CAD | -82.37% |
| 2018 | 6.34 Million CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - CAD | 0.0% |
| 2024 Q1 | - CAD | 0.0% |
| 2023 Q4 | - CAD | 100.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2023 Q1 | - CAD | 0.0% |
| 2023 FY | - CAD | 0.0% |
| 2023 Q3 | -289.59 Thousand CAD | 0.0% |
| 2022 Q2 | 339.05 CAD | -99.9% |
| 2022 Q3 | 339.05 Thousand CAD | 99900.0% |
| 2022 FY | - CAD | 0.0% |
| 2022 Q1 | 339.05 Thousand CAD | 0.0% |
| 2022 Q4 | - CAD | -100.0% |
| 2021 Q1 | 17.96 Thousand CAD | 0.0% |
| 2021 FY | - CAD | -100.0% |
| 2021 Q4 | - CAD | -100.0% |
| 2021 Q3 | 339.05 Thousand CAD | 0.0% |
| 2021 Q2 | 339.05 Thousand CAD | 1786.97% |
| 2020 Q1 | 1.16 Million CAD | 4.17% |
| 2020 FY | 17.96 Thousand CAD | -98.39% |
| 2020 Q4 | 17.96 Thousand CAD | -98.1% |
| 2020 Q3 | 945.14 Thousand CAD | 1.97% |
| 2020 Q2 | 926.92 Thousand CAD | -20.47% |
| 2019 Q3 | 1.11 Million CAD | -10.0% |
| 2019 Q2 | 1.24 Million CAD | -54.4% |
| 2019 Q1 | 2.72 Million CAD | -57.03% |
| 2019 FY | 1.11 Million CAD | -82.37% |
| 2019 Q4 | 1.11 Million CAD | -0.02% |
| 2018 Q4 | 6.34 Million CAD | 6410.31% |
| 2018 FY | 6.34 Million CAD | 0.0% |
| 2018 Q1 | - CAD | 100.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | -100.55 Thousand CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | -101.74 Thousand CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alpha Teknova, Inc. | 11.59 Million USD | 102.414% |
| Alvotech | 74.43 Million USD | 100.376% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 100.252% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 104.135% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 100.866% |
| Journey Medical Corporation | 10.2 Million USD | 102.742% |
| Dynavax Technologies Corporation | 53.29 Million USD | 100.525% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 100.426% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 102.403% |
| Bright Green Corporation | - USD | Infinity% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 100.268% |
| PainReform Ltd. | - USD | Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | 117.379% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 104.88% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 104.88% |
| SCYNEXIS, Inc. | - USD | Infinity% |
| Silver Spike Investment Corp. | - USD | Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | 134.562% |
| Embecta Corp. | 152.1 Million USD | 100.184% |
| Safety Shot Inc | 1.86 Million USD | 114.969% |
| Procaps Group, S.A. | 96.83 Million USD | 100.289% |
| Cosmos Health Inc. | 4.78 Million USD | 105.844% |
| Theratechnologies Inc. | 6.06 Million USD | 104.614% |
| Harrow Health, Inc. | 10.86 Million USD | 102.575% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 110.293% |
| Biofrontera Inc. | 10.9 Million USD | 102.566% |
| DURECT Corporation | 2.21 Million USD | 112.613% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 100.362% |
| Cronos Group Inc. | 30.33 Million USD | 100.922% |
| OptiNose, Inc. | 8.05 Million USD | 103.476% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | 27987300.0% |
| Kala Pharmaceuticals, Inc. | - USD | Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 104.911% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 100.991% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | 110.454% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 106.072% |
| Radius Health, Inc. | 278.64 Million USD | 100.1% |
| Universe Pharmaceuticals INC | 3.34 Million USD | 108.371% |
| ProPhase Labs, Inc. | 3.84 Million USD | 107.286% |
| Phibro Animal Health Corporation | 265.91 Million USD | 100.105% |
| Procaps Group S.A. | 96.83 Million USD | 100.289% |
| TherapeuticsMD, Inc. | - USD | Infinity% |
| Viatris Inc. | 3.46 Billion USD | 100.008% |
| Rockwell Medical, Inc. | 5.87 Million USD | 104.767% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 102.215% |
| SIGA Technologies, Inc. | 64.21 Million USD | 100.436% |
| Tilray Brands, Inc. | 252.08 Million USD | 100.111% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 100.7% |
| Shineco, Inc. | 1.58 Million USD | 117.618% |
| PetIQ, Inc. | 159.3 Million USD | 100.176% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | -83.189% |
| Incannex Healthcare Limited | -10.01 Million USD | 97.205% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 100.731% |
| Alimera Sciences, Inc. | 1.87 Million USD | 114.895% |
| Assertio Holdings, Inc. | 37.68 Million USD | 100.743% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 106.243% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 210.033% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 102.696% |
| Hempacco Co., Inc. | 2.54 Million USD | 111.007% |
| Talphera, Inc. | - USD | Infinity% |
| Alvotech | 74.43 Million USD | 100.376% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 100.586% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 100.437% |
| Currenc Group, Inc. | 732.91 Thousand USD | 138.186% |
| Kamada Ltd. | 87.74 Million USD | 100.319% |
| Indivior PLC | 141.79 Million USD | 100.197% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | 158.084% |
| Flora Growth Corp. | 8.5 Million USD | 103.29% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 210.033% |
| Evolus, Inc. | 10.99 Million USD | 102.545% |
| HUTCHMED (China) Limited | 50.25 Million USD | 100.557% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 100.264% |
| Akanda Corp. | 1.28 Million USD | 121.748% |